SCHEMBL22799554

SCHEMBL22799554

OCCC(OCc1ccccc1)C1CCC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
CYP3A4 P08684 1/20 0.44
SLC6A4 P31645 3/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A3 Q01959 2/20 0.41
POLB P06746 1/20 0.37
HTR2C P28335 1/20 0.37
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
ALDH1A1 P00352 3/20 0.35
TSHR P16473 1/20 0.35
GAA P10253 1/20 0.35
SGMS2 Q8NHU3 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10971393 0.80 IDO1 (0.41) CYP2C9CYP2C19CYP3A4SLC6A4SLC6A2
SCHEMBL3811153 0.73 SLC6A2 (0.45) CYP2C9CYP2C19CYP3A4SLC6A4SLC6A2
SCHEMBL7847759 0.73 HTT (0.39) CYP2C9CYP2C19CYP3A4SLC6A4SLC6A2
SCHEMBL1355001 0.72 SLC6A2 (0.44) CYP2C9CYP2C19CYP3A4SLC6A4SLC6A2
SCHEMBL12694282 0.72 TSHR (0.44) CYP2C9CYP2C19SLC6A4SLC6A2SLC6A3
SCHEMBL21727833 0.72 TSHR (0.44) CYP2C9CYP2C19SLC6A4SLC6A2SLC6A3
SCHEMBL18554463 0.72 TSHR (0.44) CYP2C9CYP2C19SLC6A4SLC6A2SLC6A3
SCHEMBL18759588 0.71 SLC6A4 (0.46) CYP2C9CYP2C19CYP3A4SLC6A4SLC6A2
SCHEMBL2791590 0.71 TDP1 (0.44) ALDH1A1
SCHEMBL3779628 0.71 CA1 (0.44) CYP2C9CYP2C19SLC6A4SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020249663-A1 NOVEL SPIROBICYCLIC INTERMEDIATES JANSSEN PHARMACEUTICA NV (BE) 2020-12-17 WO disclosed